Publications
- Tissue-type plasminogen activator (tPA) and its I-inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis1998 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis1997 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Changes in tissue-type plasminogen activator (tPA) and plasminogen inhibitor (PAI-I) during capd1996 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Tissue-type plasminogen activator (tPA) and its inhibitor (OAI-1) in CAPD1995 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Relations between echocardiographic markers and glomerular and tubular kidney functions in cardiologic patients2020 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients?2019 | Faculty of Medicine in Pilsen
- Vitamin K2, vascular calcifications and cardiovascular disease in general population and in dialysis patients2019 | Faculty of Medicine in Pilsen
- Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis2019 | Faculty of Medicine in Pilsen
- Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles2018 | Faculty of Medicine in Pilsen
- Dialysate Potassium. Srum Potassium, Mortality and Arrhytmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study2018 | Faculty of Medicine in Pilsen
Loading network view...